Skip to main content
. Author manuscript; available in PMC: 2023 Nov 17.
Published in final edited form as: Eur J Epidemiol. 2019 Jan 8;34(5):439–445. doi: 10.1007/s10654-018-0477-6

Table 1:

Comparison between mutation rates, cumulative stem cell lifetime divisions, hazard ratios for cancer in smokers and mortality rates in smokers and never smokers, for the cancer sites for which information was available in all sources.

Cancer site Mutation rates in smokersa Cumulative stem cell lifetime divisionsb Incidence hazard ratio (relative risk) for smoking menc Incidence hazard ratio (relative risk) for former smoking menc Mortality rates smokers with ≥25 cigarettes/day/non-smokersd
Lung adenocarcinoma 150.5 9.272 × 109e 23.30 5.28 415.2 / 16.9
Larynx 137.7 3.186 × 1010f 13.24 3.51 17.3 / 0
Pharynx 38.5 NA 6.67 2.06 19.4 / 0
Bladder 18.3 NA 3.84 2.15 51.4 / 13.7
Esophagus (squamous) N.S. 1.203 × 109 3.94 1.26 50.0 / 5.7
Liver 6.4 2.709 × 1011 2.92 2.09 31.3 / 4.4
Pancreas adenocarcinoma N.S. 3.428 × 1011 1.62 0.89 52.9 / 20.6
a

Statistically significant average number of somatic substitutions per genome per pack-year. From Alexandrov et al29

b

Cumulative number of divisions of stem cells per lifetime. From Tomasetti and Vogelstein1

c

From Agudo et al15

d

Cumulative mortality rate per 100,000 persons per year, from Doll et al36

e

Cumulative number of divisions of stem cells per lifetime. From Tomasetti and Vogelstein1

f

Adenocarcinoma (same rate in smokers and non-smokers)